PDSB · Healthcare · $41M
After-hours $0.73-1.32%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 541 Biotechnology peers
“이번 분기 가장 큰 뉴스는 핵심 임상시험 'VERSATILE-003'의 설계를 FDA와 협의해 바꾼 거예요.”
In the company's words · 2026 1분기 earnings call